PD-1/PD-L1 inhibitor 1
99%
- Product Code: 99228
CAS:
1675201-83-8
| Molecular Weight: | 475.58 g./mol | Molecular Formula: | C₂₉H₃₃NO₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
PD-1/PD-L1 inhibitor 1 is primarily used in immunotherapy for cancer treatment. It works by blocking the interaction between PD-1, a protein on immune cells, and PD-L1, a protein on cancer cells. This blockade helps to activate the immune system, enabling it to recognize and attack cancer cells more effectively. It is particularly significant in treating various types of cancers, including melanoma, non-small cell lung cancer, and renal cell carcinoma, where traditional therapies may have limited effectiveness. By enhancing the body's natural immune response, this inhibitor plays a crucial role in improving patient outcomes and survival rates in advanced or metastatic cancer cases.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white Solid |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $440.98 |
+
-
|
| 0.025 | 10-20 days | $1,456.05 |
+
-
|
PD-1/PD-L1 inhibitor 1
PD-1/PD-L1 inhibitor 1 is primarily used in immunotherapy for cancer treatment. It works by blocking the interaction between PD-1, a protein on immune cells, and PD-L1, a protein on cancer cells. This blockade helps to activate the immune system, enabling it to recognize and attack cancer cells more effectively. It is particularly significant in treating various types of cancers, including melanoma, non-small cell lung cancer, and renal cell carcinoma, where traditional therapies may have limited effectiveness. By enhancing the body's natural immune response, this inhibitor plays a crucial role in improving patient outcomes and survival rates in advanced or metastatic cancer cases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :